A Cyclin-Dependent Kinase Inhibitor, p16INK4A, Induces Apoptosis in the Human Cancer Cells

Korean Journal of Microbiology and Biotechnology

Volumn 32, Issue 1, 2004, Pages 72-77

  Kim, Min Kyoung ^a   Lee, Chul Hoon ^a  

^a Hanyang University College of Medicine   (South Korea)

Author keywords

Apoptosis; Cell cycle arrest; p16INK4A

Indexed keywords

CASPASE 3; COMPLEMENTARY DNA; CYCLIN DEPENDENT KINASE INHIBITOR; PROPIDIUM IODIDE; PROTEIN P16;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CELL CYCLE; CONTROLLED STUDY; CYTOTOXICITY; DNA VECTOR; ENZYME DEGRADATION; GENE EXPRESSION; GENETIC TRANSFECTION; HELA CELL; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; NICK END LABELING; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REGULATORY MECHANISM; STAINING; TUMOR CELL; TUMOR SUPPRESSOR GENE; WILD TYPE;

EID: 1842785600     PISSN: 1598642X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Burns, Timothy F. and Wafik S. El-deiry. 1999. The p53 Pathway and apoptosis. J. Cell. Physiol. 181: 231-239.
2. Chin, Lynda, Jason P., and Ronald. A. DePinho. 1998. The INK4a/ARF tumor suppressor: one gene-two products- two pathways. Trends. Biochem. Sci. 23: 291-296.
3. Chun, M. W., D. H. Shin, S. Y. Song, Y. H. Lee, C. H. Lee, L. S. Jeong and S. K. Lee, 1999. Synthesis of L-Sangivamycin and Toyocamycin analogues and their inhibitory activities of Ser/Thr protein kinases. Nucleosides Nucleotides 18: 617-618.
4. Clarke, A. R., C. A. Purdie, D. J. Harrison, R. G. Morris, C. C. Bird, M. L. Hooper and A. H. Wyllie. 1993. Thymocyte apoptosis induced by p53-dependent and independent pathway. Nature 362: 849-852.
5. Gey, G. O., W. D. Coffman, and M. T. Kubicek. 1952. Tissue culture studies of the proliferative capacity of cervical carcinoma and normal epithelium. Cancer Res. 12: 264-265.
6. Kamb, A., N. A. Gruis, J. Weaver-Feidhaus, Q. Liu, K. Harshman, S. V. Tavtigian, E. Stockert, R. S. III Day, B. E. Johnson, and M. H. Skolnick. 1994. A cell cycle regulator potentially involved in genesis of many tumor types. Science 264: 436-440.
7. Kamesaki, H. 1998. Mechanisms involved in chemotherapy-induced apoptosis and their implication in cancer chemotherapy. Int. J. Hematol. 68(1): 29-43.
8. INK4A-mediated apoptosis in non-small cell lung cancer cells. Oncogene 19: 1580-1595.
9. INK4A protein. Cell Death. Differ. 7: 706-711.
10. Koh, J., G. H. Enders, B. D. Dynlacht, and E. Harlow. 1995. Tumour derived p16 alleles encoding proteins defective in cell-cycle inhibition. Nature 375: 506-510.
11. Lowe, S. W., E. M. Schmitt, S. W. Smith, B. A. Osbome, and T. Jacks. 1993. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362: 847-852.
12. Lukas, J., D. Parry, L. Aagaard, D. J. Mann, J. Bartkova, M. Strauss, G. Peters, and J. Bartek. 1995. Retinoblastoma-protein-dependent cell cycle inhibition by the tumour suppressor p16. Nature 375: 503-506.
13. Macleod, Kay. 2000. Tumor suppressor genes. Curr. Opin. Genet. Dev. 10: 81-93.
14. McConnell, B. B., F. J. Gregory, F. J. Stott, E. Hara, and G. Peters. 1999. Induced expression of p16(INK4A) inhibits both CDK4- and CDK2-associated kinase activity by reassortment of cyclin-CDK-inhibitor complex. Mol. Cell. Biol. 19: 1981-1989.
15. Miyashita, T. and J. C. Reed. 1995. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80: 293-299.
16. Park, S., J. Cheon, Y. Lee, J. Park, K. Lee, C.-H. Lee and S. Lee. 1996. A Specific Inhibitor of Cyclin-Dependent Protein Kinases, CDC2 and CDK2. Mol. Cells 6: 679-683.
17. Ruas, M. and G. Peters. 1998. The p16INK4a/CDKN2A tumor suppressor and its relatives. Biochim. Biophys. Acta. 1378: F115-117.
18. Sambrook, J. and D.W. Russell. 2001. Molecular Cloning: A Laboratory manual, pp 16.47-16.57. 3th ed. CSHL Press, Cold Spring Harbor, New York, U.S.A.
19. Scheffner, M. 1991. The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines. Proc. Natl. Acad. Sci. USA 88: 5523-5527.
20. Serrano, M., G.J. Hannon, and D. Beach. 1993. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366: 704-707.
21. Sharpless, Norman E., and Ronald A. DePinho. 1999. The INK4a/ARF locus and its two gene products. Curr. Opin. Genet. Dev. 9: 22-30.
22. Takahashi, T. 1989. p53: A frequent target for genetic abnormalities in lung cancer. Science 246: 491-494.
23. Tang, Kit S., Benjamin J. Guralnick, Wooi Koon Wang, Alan R. Fersht, and Laura S. Itzhaki. 1999. Stability and Folding of the Tumor Suppressor Protein p16. J. Mol. Biol. 285: 1869-1886.
24. Vaux, D. L. and A. Strasser. 1996. The molecular biology of apoptosis. Proc. Natl. Acad. Sci. USA 93: 2239-2244.
25. Vidal, A. and K. Andrew. 2000. Cell-cycle inhibitors: three families united by a common cause. Gene 247: 1-15.